These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Drug absorption and bioavailability problems of tablets and capsules]. Cascioli D; Petrangeli B Boll Chim Farm; 1978 Aug; 117(8):437-51. PubMed ID: 743388 [No Abstract] [Full Text] [Related]
3. [Drugs and the organism. II. Bioavailability]. Pflegel P; Pfeifer S Pharmazie; 1980; 34(5-6):337-59. PubMed ID: 6893363 [No Abstract] [Full Text] [Related]
4. [Possibilities and problems of organ-selective active principles and drugs]. Hamacher H Pharmazie; 1981 Jun; 36(6):391-9. PubMed ID: 7025022 [No Abstract] [Full Text] [Related]
7. Parabolic structure-activity relationships: a simple pharmacokinetic model. Aarons L; Bell D; Waigh R; Ye Q J Pharm Pharmacol; 1982 Nov; 34(11):746-9. PubMed ID: 6129312 [No Abstract] [Full Text] [Related]
8. Pharmacokinetic properties and their relation to certain physicochemical properties. Seydel JK Eur J Toxicol Hyg Environ; 1972; 5(5 Suppl):39-52. PubMed ID: 14732950 [No Abstract] [Full Text] [Related]
9. Liposomes as drug carriers. Fendler JH; Romero A Life Sci; 1977 Apr; 20(7):1109-20. PubMed ID: 403379 [No Abstract] [Full Text] [Related]
10. Drug effects in clinical chemistry. Part 2. Guidelines for evaluation of analytical interference. Galteau MM; Siest G J Clin Chem Clin Biochem; 1984 Mar; 22(3):275-9. PubMed ID: 6726127 [No Abstract] [Full Text] [Related]
11. [Biological availability of drugs]. Holovkin VO Farm Zh; 1979; (2):20-5. PubMed ID: 456507 [No Abstract] [Full Text] [Related]
12. Pharmacokinetic considerations in the haemodialysis of drugs. Parker PR; Parker WA J Clin Hosp Pharm; 1982 Jun; 7(2):87-99. PubMed ID: 7050183 [TBL] [Abstract][Full Text] [Related]
13. [Utilization of analog computers in the development of dosage forms]. Frömming KH; Lippold B; Garrett ER Mitt Dtsch Pharm Ges Pharm Ges DDR; 1971 Sep; 41(9):205-47. PubMed ID: 4939073 [No Abstract] [Full Text] [Related]
14. The integration of organic and physical chemistry and professional activities. Krówczyński L Farmaco Prat; 1977 Oct; 32(10):475-91. PubMed ID: 923760 [No Abstract] [Full Text] [Related]
15. Physicochemical interpretation of the pharmacokinetics of percutaneous absorption. Guy RH; Hadgraft J J Pharmacokinet Biopharm; 1983 Apr; 11(2):189-203. PubMed ID: 6886974 [TBL] [Abstract][Full Text] [Related]
17. Physiological and physicochemical bases of drug interactions in man. Dayton PG; Perel JM Ann N Y Acad Sci; 1971 Jul; 179():67-87. PubMed ID: 4105795 [No Abstract] [Full Text] [Related]
18. Drug levels in the target tissue and effect. Ariëns EJ Clin Pharmacol Ther; 1974 Jul; 16(1):155-75. PubMed ID: 4367253 [No Abstract] [Full Text] [Related]
19. Bioavailability of drugs (first of two parts). Koch-Weser J N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408 [No Abstract] [Full Text] [Related]
20. [Mechanisms of pharmacokinetic drug interactions. 2: Interaction mechanisms during absorption]. Heydel E; Box A; Fürtig W Pharmazie; 1984 Feb; 39(2):129-36. PubMed ID: 6371841 [No Abstract] [Full Text] [Related] [Next] [New Search]